Aimei Health Technology (AFJK) Shares Outstanding (Weighted Average) (2023 - 2025)

Aimei Health Technology (AFJK) has 3 years of Shares Outstanding (Weighted Average) data on file, last reported at $4.4 million in Q3 2025.

• Shares Outstanding (Weighted Average) for Q3 2025 came in at $4.4 million, up 105.96% year-over-year; the trailing twelve-month figure through Sep 2025 was $4.4 million (up 105.96% YoY), and the FY2024 annual result was $2.1 million, up 38.21% from the prior year.
• Shares Outstanding (Weighted Average) improved to $4.4 million in Q3 2025 per AFJK's latest filing, from $4.0 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $6.9 million in Q1 2024 and troughed at $1.5 million in Q4 2023.
• A 3-year average of $3.8 million and a median of $3.1 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 105.96% in 2025 and fell as far as 69.19% in 2025.
• A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $1.5 million in 2023, then soared by 38.21% to $2.1 million in 2024, then jumped by 105.96% to $4.4 million in 2025.
• Business Quant data shows AFJK's Shares Outstanding (Weighted Average) at $4.4 million in Q3 2025, $4.0 million in Q2 2025, and $2.1 million in Q1 2025.